Evidence map›Paper›PMID 38278785›Full record

ArticleNature communications2024

Uncovering supramolecular chirality codes for the design of tunable biomaterials.

Stephen J Klawa, Michelle Lee, Kyle D Riker, Tengyue Jian, Qunzhao Wang, Yuan Gao, Margaret L Daly, Shreeya Bhonge, W Seth Childers, Tolulope O Omosun and 3 more

Abstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. 2D Interfacial Crystallization Stabilized by Short-Chain Aliphatic Interfaces.Langmuir : the ACS journal of surfaces and colloids · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Stephen J KlawaDepartment of Applied Physical Sciences, University of North Carolina, Chapel Hill, NC, 27599, USA.ORCID 0000-0003-2416-7721
Michelle LeeDepartment of Chemistry, Emory University, Atlanta, GA, 30322, USA.ORCID 0009-0005-7457-102X
Kyle D RikerDepartment of Applied Physical Sciences, University of North Carolina, Chapel Hill, NC, 27599, USA.ORCID 0000-0003-4788-8687
Tengyue JianDepartment of Applied Physical Sciences, University of North Carolina, Chapel Hill, NC, 27599, USA.
Qunzhao WangDepartment of Applied Physical Sciences, University of North Carolina, Chapel Hill, NC, 27599, USA.
Yuan GaoDepartment of Applied Physical Sciences, University of North Carolina, Chapel Hill, NC, 27599, USA.
Margaret L DalyDepartment of Applied Physical Sciences, University of North Carolina, Chapel Hill, NC, 27599, USA.ORCID 0000-0003-2248-3632
Shreeya BhongeDepartment of Applied Physical Sciences, University of North Carolina, Chapel Hill, NC, 27599, USA.
W Seth ChildersDepartment of Chemistry, Emory University, Atlanta, GA, 30322, USA.ORCID 0000-0003-1160-7767
Tolulope O OmosunDepartment of Chemistry, Emory University, Atlanta, GA, 30322, USA.
Anil K MehtaDepartment of Chemistry, Emory University, Atlanta, GA, 30322, USA.ORCID 0000-0002-9867-151X
David G LynnDepartment of Chemistry, Emory University, Atlanta, GA, 30322, USA. dlynn2@emory.edu.ORCID 0000-0003-2200-059X
Ronit FreemanDepartment of Applied Physical Sciences, University of North Carolina, Chapel Hill, NC, 27599, USA. ronifree@email.unc.edu.ORCID 0000-0001-5960-6689

Funding

Virology Research Program (Program 4)P30CA016086 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Deborah F. Tate · 1985 to 2026
$201.5M
Implementing a Maternal health and PRegnancy Outcomes Vision for Everyone (IMPROVE)UL1TR002378 · NCATS · EMORY UNIVERSITY · PI Andres J Garcia, Elizabeth O. Ofili · 2017 to 2026
$92.1M
Atlanta Clinical and Translational Science Institute (ACTSI) RenewalUL1TR000454 · NCATS · EMORY UNIVERSITY · PI STEPHENS, DAVID S · 2012 to 2016
$25.8M
The Emory Alzheimer's Disease CenterP50AG025688 · NIA · EMORY UNIVERSITY · PI LEVEY, ALLAN I · 2005 to 2019
$25.7M
UNC Medical Scientist Training ProgramT32GM152316 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Toni Darville, Mohanish P Deshmukh · 2024 to 2026
$4.3M
NCATS NIH HHS UL1 TR000454NCATS NIH HHS UL1 TR002378NCI NIH HHS P30 CA016086NIA NIH HHS P50 AG025688NIGMS NIH HHS T32 GM152316
6 · The paper itself

Abstract

In neurodegenerative diseases, polymorphism and supramolecular assembly of β-sheet amyloids are implicated in many different etiologies and may adopt either a left- or right-handed supramolecular chirality. Yet, the underlying principles of how sequence regulates supramolecular chirality remains unknown. Here, we characterize the sequence specificity of the central core of amyloid-β 42 and design derivatives which enable chirality inversion at biologically relevant temperatures. We further find that C-terminal modifications can tune the energy barrier of a left-to-right chiral inversion. Leveraging this design principle, we demonstrate how temperature-triggered chiral inversion of peptides hosting therapeutic payloads modulates the dosed release of an anticancer drug. These results suggest a generalizable approach for fine-tuning supramolecular chirality that can be applied in developing treatments to regulate amyloid morphology in neurodegeneration as well as in other disease states.

Indexed as

AmyloidAmyloid beta-PeptidesTemperatureAmyloidAmyloid beta-Peptides

Identifiers

PMID38278785
PMCPMC10817930

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.